Source:

Press Release

April 12, 2021
1 min read
Save

Research initiative to focus on new glaucoma treatments

Source:

Press Release

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Santen, Massachusetts Eye and Ear and Ulster University have formed a research initiative to investigate and develop novel therapies for the treatment of glaucoma, according to a press release.

The initiative aims to prevent vision impairment or loss by “slowing, reversing or preventing” damage to the optic nerve, the release said.

“Our research aims to determine if targeting a component of the immune system called the NLRP3 inflammasome, with a novel biologic we developed in collaboration with Dr. Victoria McGilligan, will stop the degeneration of optic nerve cells and help preserve vision in glaucoma patients,” Meredith S. Gregory-Ksander, PhD, an associate scientist at Schepens Eye Research Institute of Mass Eye and Ear and assistant professor of ophthalmology at Harvard Medical School, said in the release.